Inhibition of cell death To investigate the potential protective effects of a given compound against RBC death, experiments must be designed to subject the cells to different physical and chemical stressors with and without the compound of interest, and multiple toxic endpoints are then examined
To this aim, there has been a blooming effort in the development of potential CD38 inhibitors, which fall into different categories, such as small-molecule compounds, natural inhibitors, and antibody approaches
Furthermore, in some tumours, the need for methyl groups for epigenetic regulation prevents activation of the trans-sulphuration pathway for cysteine synthesis, instead prioritising one-carbon metabolism
It is found in many tissues in the body
PMCID: PMC7353203
Adjustments are common and expected peptide therapy is precision medicine, not one-size-fits-all